142 related articles for article (PubMed ID: 28405888)
1. Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.
Matosin N; Newell KA; Quidé Y; Andrews JL; Teroganova N; Green MJ; Fernandez F
Brain Imaging Behav; 2018 Apr; 12(2):509-517. PubMed ID: 28405888
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
3. Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
Matosin N; Fernandez-Enright F; Lum JS; Andrews JL; Engel M; Huang XF; Newell KA
Schizophr Res; 2015 Aug; 166(1-3):212-8. PubMed ID: 26048293
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals.
Dickinson D; Straub RE; Trampush JW; Gao Y; Feng N; Xie B; Shin JH; Lim HK; Ursini G; Bigos KL; Kolachana B; Hashimoto R; Takeda M; Baum GL; Rujescu D; Callicott JH; Hyde TM; Berman KF; Kleinman JE; Weinberger DR
JAMA Psychiatry; 2014 Jun; 71(6):647-56. PubMed ID: 24718902
[TBL] [Abstract][Full Text] [Related]
5. An exploratory model for G x E interaction on hippocampal volume in schizophrenia; obstetric complications and hypoxia-related genes.
Haukvik UK; Saetre P; McNeil T; Bjerkan PS; Andreassen OA; Werge T; Jönsson EG; Agartz I
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1259-65. PubMed ID: 20638435
[TBL] [Abstract][Full Text] [Related]
6. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
Egan MF; Straub RE; Goldberg TE; Yakub I; Callicott JH; Hariri AR; Mattay VS; Bertolino A; Hyde TM; Shannon-Weickert C; Akil M; Crook J; Vakkalanka RK; Balkissoon R; Gibbs RA; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12604-9. PubMed ID: 15310849
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
Rose EJ; Hargreaves A; Morris D; Fahey C; Tropea D; Cummings E; Caltagirone C; Bossù P; Chiapponi C; Piras F; Spalletta G; Gill M; Corvin A; Donohoe G
Br J Psychiatry; 2014 Feb; 204(2):115-21. PubMed ID: 24311551
[TBL] [Abstract][Full Text] [Related]
8. [Association of glutamate receptor metabotropic 5 polymorphisms with schizophrenia susceptibility in a Chinese Han population].
Song M; Liu Y; Wang XJ; Zhang LW; Liu Q; Chen TF; Su X; Li WW; Lyu LX; Yang YF
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(27):2108-2114. PubMed ID: 35844113
[No Abstract] [Full Text] [Related]
9. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia.
Zurawek D; Salerno-Kochan A; Dziedzicka-Wasylewska M; Nikiforuk A; Kos T; Popik P
Schizophr Res; 2018 Feb; 192():423-430. PubMed ID: 28433499
[TBL] [Abstract][Full Text] [Related]
10. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
11. The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia.
Devon RS; Anderson S; Teague PW; Muir WJ; Murray V; Pelosi AJ; Blackwood DH; Porteous DJ
Mol Psychiatry; 2001 May; 6(3):311-4. PubMed ID: 11326300
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor 5 neuroimaging in schizophrenia.
Akkus F; Treyer V; Ametamey SM; Johayem A; Buck A; Hasler G
Schizophr Res; 2017 May; 183():95-101. PubMed ID: 27847228
[TBL] [Abstract][Full Text] [Related]
13. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
Walters JT; Rujescu D; Franke B; Giegling I; Vásquez AA; Hargreaves A; Russo G; Morris DW; Hoogman M; Da Costa A; Moskvina V; Fernández G; Gill M; Corvin A; O'Donovan MC; Donohoe G; Owen MJ
Am J Psychiatry; 2013 Aug; 170(8):877-85. PubMed ID: 23903335
[TBL] [Abstract][Full Text] [Related]
14. Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.
Matosin N; Fernandez-Enright F; Lum JS; Newell KA
Neuropharmacology; 2017 Mar; 115():73-91. PubMed ID: 26349010
[TBL] [Abstract][Full Text] [Related]
15. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
[TBL] [Abstract][Full Text] [Related]
16. Rare damaging variants in DNA repair and cell cycle pathways are associated with hippocampal and cognitive dysfunction: a combined genetic imaging study in first-episode treatment-naive patients with schizophrenia.
Yang Z; Li M; Hu X; Xiang B; Deng W; Wang Q; Wang Y; Zhao L; Ma X; Sham PC; Northoff G; Li T
Transl Psychiatry; 2017 Feb; 7(2):e1028. PubMed ID: 28195569
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
Szeszko PR; Lipsky R; Mentschel C; Robinson D; Gunduz-Bruce H; Sevy S; Ashtari M; Napolitano B; Bilder RM; Kane JM; Goldman D; Malhotra AK
Mol Psychiatry; 2005 Jul; 10(7):631-6. PubMed ID: 15768049
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study.
Hasan A; Wobrock T; Falkai P; Schneider-Axmann T; Guse B; Backens M; Ecker UK; Heimes J; Galea JM; Gruber O; Scherk H
World J Biol Psychiatry; 2014 Apr; 15(3):188-99. PubMed ID: 22047183
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
[TBL] [Abstract][Full Text] [Related]
20. Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis.
Harrisberger F; Smieskova R; Vogler C; Egli T; Schmidt A; Lenz C; Simon AE; Riecher-Rössler A; Papassotiropoulos A; Borgwardt S
Transl Psychiatry; 2016 Aug; 6(8):e868. PubMed ID: 27505231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
